Cellectar Biosciences Inc
PUT
$0
33.8K
Q3 2024
Added 17.77%
CALL
$12,000
5.9K
Q3 2024
Added 27.27%
PUT
$2,000
1.4K
Q3 2024
Added 27.27%
CALL
$0
17.8K
Q3 2024
Reduced 87.5%
PUT
$0
200
Q3 2024
Reduced 87.5%
CALL
$699,000
115K
Q3 2024
Added 314.29%
PUT
$158,000
26.1K
Q3 2024
Added 314.29%
CALL
$6.13 Million
366K
Q3 2024
Added 9.18%
PUT
$23.2 Million
1.38M
Q3 2024
Added 9.18%
CALL
$9.75 Million
332K
Q3 2024
Added 373.58%
PUT
$738,000
25.1K
Q3 2024
Added 373.58%
CALL
$380,000
53K
Q3 2024
Reduced 20.53%
PUT
$239,000
33.3K
Q3 2024
Reduced 20.53%
CALL
$253,000
3.6K
Q3 2024
Reduced 10.71%
PUT
$176,000
2.5K
Q3 2024
Reduced 10.71%
CALL
$94,000
5.9K
Q3 2024
Added 883.33%
PUT
$471,000
29.5K
Q3 2024
Added 883.33%
CALL
$783,000
21.5K
Q3 2024
New holding
PUT
$510,000
14K
Q3 2024
New holding
PUT
$47,000
1.5K
Q3 2024
New holding
CALL
$1.39 Million
47K
Q3 2024
Added 200.0%
PUT
$8,000
300
Q3 2024
Added 200.0%
CALL
$111,000
11.8K
Q3 2024
Added 48.54%
PUT
$144,000
15.3K
Q3 2024
Added 48.54%
CALL
$6.6 Million
120K
Q3 2024
Added 59.51%
PUT
$5.7 Million
104K
Q3 2024
Added 59.51%
CALL
$1.37 Million
84.5K
Q3 2024
Added 200.72%
PUT
$1.35 Million
83K
Q3 2024
Added 200.72%
CALL
$22,000
8.9K
Q3 2024
Reduced 19.09%
CALL
$1.53 Million
14.9K
Q3 2024
Reduced 7.0%
PUT
$1.91 Million
18.6K
Q3 2024
Reduced 7.0%
CALL
$14,000
8.7K
Q3 2024
Added 3300.0%
PUT
$17,000
10.2K
Q3 2024
Added 3300.0%
CALL
$90,000
33K
Q3 2024
Reduced 87.35%
PUT
$11,000
4.1K
Q3 2024
Reduced 87.35%
CALL
$335,000
107K
Q3 2024
Reduced 55.56%
PUT
$303,000
96.3K
Q3 2024
Reduced 55.56%
CALL
$58,000
5K
Q3 2024
Added 20.75%
PUT
$224,000
19.2K
Q3 2024
Added 20.75%
CALL
$39,000
22.5K
Q3 2024
Added 66.2%
PUT
$41,000
23.6K
Q3 2024
Added 66.2%
CALL
$41,000
1.7K
Q3 2024
Added 411.11%
PUT
$111,000
4.6K
Q3 2024
Added 411.11%
PUT
$25.1 Million
292K
Q3 2024
Reduced 50.42%
PUT
$0
20.2K
Q3 2024
Added 23.93%
CALL
$2.04 Million
17.7K
Q3 2024
Reduced 51.52%
PUT
$184,000
1.6K
Q3 2024
Reduced 51.52%
CALL
$3.46 Million
36.4K
Q3 2024
Added 78.08%
PUT
$2.47 Million
26K
Q3 2024
Added 78.08%
CALL
$801,000
26.6K
Q3 2024
Reduced 23.72%